[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@fwpharma Avatar @fwpharma FirstWord Pharma

FirstWord Pharma posts on X about $alks, $avdl, $azn, $mrk the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXXX% currencies XXXX% countries XXXX%

Social topic influence $alks 8.16%, $avdl 8.16%, $azn #24, $mrk 6.12%, $pfe #66, $lly #42, $rhhby 4.08%, $agio 2.04%, $sny 2.04%, $idya XXXX%

Top accounts mentioned or mentioned by @mcflusion @wolterskluwers

Top assets mentioned Alkermes Inc. plc (ALKS) AstraZeneca PLC (AZN) Merck & Co., Inc. (MRK) Pfizer, Inc. (PFE) Eli Lilly and Company (LLY) Agios Pharmaceuticals, Inc. (AGIO) Synthetify (SNY) IDEAYA Biosciences, Inc. Common Stock (IDYA) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Amgen, Inc. (AMGN) Halozyme Therapeutics, Inc. (HALO) Gilead Sciences, Inc. (GILD) Arcellx, Inc. Common Stock (ACLX) Novartis AG (NVS) Bristol-Myers Squibb Co (BMY) Kymera Therapeutics, Inc. Common Stock (KYMR) Johnson & Johnson (JNJ) Regeneron Pharmaceuticals Inc (REGN)

Top Social Posts

Top posts by engagements in the last XX hours

"Early findings for AstraZeneca's dual-targeted CAR-T show XXX% ORR in MM #ASH25 $AZN"
X Link 2025-12-08T10:21Z 55.1K followers, 4901 engagements

"Agios still awaiting FDA decision on Pyrukynd thalassemia filing $AGIO"
X Link 2025-12-08T22:31Z 55.1K followers, XXX engagements

"FDA is 'rigorously reviewing' RSV antibody safety in infants $MRK $SNY $AZN"
X Link 2025-12-09T23:16Z 55.1K followers, XXX engagements

"IDEAYA's darovasertib impresses in twin ocular cancer trials $IDYA"
X Link 2025-10-20T21:55Z 55.1K followers, XXX engagements

"Rhythm's Imcivree faces extended FDA clock in hypothalamic obesity bid $RYTM"
X Link 2025-11-07T16:47Z 55.1K followers, XXX engagements

"Lundbeck tries to upend Alkermes' takeout of sleep drug developer Avadel $HLBBF $ALKS $AVDL"
X Link 2025-11-14T22:32Z 55.1K followers, XXX engagements

"Sandoz's Tysabri #biosimilar hits US market following delays to JCV assay $SDZ"
X Link 2025-11-17T12:51Z 55.1K followers, XXX engagements

"Alkermes' move as Avadel deems Lundbeck counterbid superior $AVDL $ALKS"
X Link 2025-11-18T22:42Z 55.1K followers, XXX engagements

"Alkermes sweetens Avadel bid in effort to stave off rival Lundbeck $ALKS $AVDL"
X Link 2025-11-19T12:18Z 55.1K followers, XXX engagements

"Merck & Co.'s HIV tablet matches Biktarvy in treatment-nave patients $MRK"
X Link 2025-11-19T22:23Z 55.1K followers, XXX engagements

"Lundbeck bows out of Avadel pursuit days after Alkermes upped its bid $ALKS $AVDL"
X Link 2025-11-26T18:42Z 55.1K followers, XXX engagements

"Generate:Biomedicines' AI-engineered TSLP antibody headed to Phase III $AMGN $AZN"
X Link 2025-12-01T19:26Z 55.1K followers, XXX engagements

"Daiichi escapes Enhertu royalties as appeals court tosses Seagen ADC patent claims $DSNKY $PFE"
X Link 2025-12-03T21:45Z 55.1K followers, XXX engagements

"Excelsior raises $95M for AI 'smart bloccs' that can boost drug discovery manufacturing"
X Link 2025-12-03T21:47Z 55.1K followers, XXX engagements

"Junevity adds $10M to seed round after unveiling lead siRNA for obesity diabetes"
X Link 2025-12-03T22:49Z 55.1K followers, XXX engagements

"CervoMed on cusp of pivotal trial for dementia drug after tumultuous year $CRVO #CTAD25"
X Link 2025-12-05T08:13Z 55.1K followers, XXX engagements

"German court blocks Merck & Co.'s Keytruda SC amid patent clash $MRK $HALO"
X Link 2025-12-05T19:58Z 55.1K followers, XXX engagements

"Anito-cel keeps its neurotox profile clean MM survival rates high after two years #ASH25 $GILD $ACLX"
X Link 2025-12-08T10:22Z 55.1K followers, 1182 engagements

"Lilly presents case for earlier use of Jaypirca after topping Imbruvica in key study #ASH25 $LLY"
X Link 2025-12-08T10:22Z 55.1K followers, XXX engagements

"Novartis partners with Relation to discover new targets for atopic diseases $NVS"
X Link 2025-12-09T10:58Z 55.1K followers, 1181 engagements

"BioNTech BMS flex upbeat interim mid-stage data for PD-L1/VEGF-A in TNBC #SABCS25 $BMY $BNTX"
X Link 2025-12-09T12:49Z 55.1K followers, 1164 engagements

"Liver signals again trigger partial FDA hold on Roche's fenebrutinib MS studies $RHHBY"
X Link 2025-12-09T18:58Z 55.1K followers, XXX engagements

"Atopic dermatitis data bolster Kymera's hopes of matching Dupixent's efficacy with oral STAT6 degrader $KYMR"
X Link 2025-12-08T13:34Z 55.1K followers, XXX engagements

"Roche wins EU approval for Gazyvaro in lupus nephritis $RHHBY"
X Link 2025-12-09T18:57Z 55.1K followers, XXX engagements

"Cell therapy manufacturer Cellular Origins snags support from J&J in $40M fundraise $JNJ"
X Link 2025-12-10T02:52Z 55.1K followers, XXX engagements

"Pfizer signals leaner operations in Switzerland $PFE"
X Link 2025-12-10T23:16Z 55.1K followers, XXX engagements

"Pfizer Regeneron back TRIANA's $120M raise to advance lead molecular glue $PFE $REGN"
X Link 2025-12-03T21:46Z 55.1K followers, 1025 engagements

"Zealand's ambitious plans to move beyond the 'weight-loss Olympics' $ZEAL"
X Link 2025-12-11T11:21Z 55.1K followers, XXX engagements

"Lilly's 'triple-G' drug leads to XXXX% weight loss in first pivotal test $LLY"
X Link 2025-12-11T12:37Z 55.1K followers, XXX engagements